Prosight Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-20,000	Closed	-$333K	–	31
2022 Q1	$333K	Sell	20,000 -48,800	-71%	-$755K	0.23%	31
2021 Q4	$1.31M	Sell	68,800 -205,961	-75%	-$4.53M	0.87%	28
2021 Q3	$6.78M	Buy	274,761 +135,875	+98%	+$3.2M	3.96%	7
2021 Q2	$3.61M	Buy	+138,886	New	+$3.61M	2.29%	19
2020 Q4	–	Sell	-120,606	Closed	-$3.97M	–	50
2020 Q3	$3.97M	Sell	120,606 -94,394	-44%	-$2.89M	1.96%	21
2020 Q2	$5.9M	Sell	215,000 -338,100	-61%	-$11.1M	2.93%	16
2020 Q1	$16.6M	Buy	553,100 +164,500	+42%	+$4.36M	7.79%	2
2019 Q4	$10.8M	Buy	388,600 +42,451	+12%	+$966K	4.92%	7
2019 Q3	$6.3M	Sell	346,149 -53,851	-13%	-$1.19M	3.51%	10
2019 Q2	$9.81M	Sell	400,000 -517,080	-56%	-$7.79M	4.99%	5
2019 Q1	$8.72M	Sell	917,080 -145,420	-14%	-$1.41M	4%	8
2018 Q4	$9.4M	Buy	1,062,500 +347,183	+49%	+$3.35M	4.85%	7
2018 Q3	$8.05M	Buy	715,317 +275,417	+63%	+$3.91M	4.56%	8
2018 Q2	$5.63M	Buy	439,900 +230,058	+110%	+$3.36M	4.13%	9
2018 Q1	$3.55M	Sell	209,842 -297,010	-59%	-$4.5M	2.31%	17
2017 Q4	$4.05M	Buy	+506,852	New	+$4.07M	3.02%	14